Related references
Note: Only part of the references are listed.miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
Xin-Ge Zhao et al.
CELL DEATH & DISEASE (2019)
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
Linh Khanh Huynh et al.
BIOMOLECULES (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis
Olga Fedorova et al.
ONCOGENE (2019)
PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis
Hsi-Wen Yeh et al.
NATURE CELL BIOLOGY (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
Driton Vela et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases
Ricardo Rodriguez-Calvo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling
Zhe Ying et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma
Ming-Fang Cheng et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes
Alexander J. A. Deutsch et al.
CANCER RESEARCH (2017)
Signaling Receptors for TGF-β Family Members
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer
Chung-Min Yeh et al.
SCIENTIFIC REPORTS (2016)
14-3-3ζ Turns TGF-β's Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2
Jia Xu et al.
CANCER CELL (2015)
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Katrin Palumbo-Zerr et al.
NATURE MEDICINE (2015)
The NR4A orphan nuclear receptors: mediators in metabolism and diseases
Harmit S. Ranhotra
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Pericellular proteolysis in cancer
Lisa Sevenich et al.
GENES & DEVELOPMENT (2014)
Minireview: Role Of Orphan Nuclear Receptors in Cancer and Potential as Drug Targets
Stephen Safe et al.
MOLECULAR ENDOCRINOLOGY (2014)
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies
Michael J. Duffy et al.
BREAST CANCER RESEARCH (2014)
uPA/PAI-1 ratios distinguish benign prostatic hyperplasia and prostate cancer
Lothar Boehm et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
The Apparent uPA/PAI-1 Paradox in Cancer: More than Meets the Eye
Hau C. Kwaan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Iron and cancer: more ore to be mined
Suzy V. Torti et al.
NATURE REVIEWS CANCER (2013)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The influence of matriptase-2 on prostate cancer in vitro: A possible role for β-catenin
Siobhan L. Webb et al.
ONCOLOGY REPORTS (2012)
Iron regulatory protein-1 and-2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins
Mayka Sanchez et al.
BLOOD (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
M. Petersen et al.
ONCOGENE (2010)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
Alicia R. Folgueras et al.
BLOOD (2008)
The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
Laura Silvestri et al.
CELL METABOLISM (2008)
The type II transmembrane serine protease Matriptase-2 - identification, structural features, enzymology, expression pattern and potential roles
Andrew J. Ramsay et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation
Andrew J. Sanders et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients
Christian Parr et al.
CLINICAL CANCER RESEARCH (2007)
Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia
Shannon E. Mullican et al.
NATURE MEDICINE (2007)
The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor β-induced growth inhibition that is inactivated in pancreatic cancer
Anita Buck et al.
MOLECULAR CANCER RESEARCH (2006)
JNK mediates TGF-β1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes
Juan F. Santibanez
FEBS LETTERS (2006)
Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis
M. C. Perttu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2006)
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
JL Babitt et al.
NATURE GENETICS (2006)
The urokinase plasminogen activator system: Role in malignancy
MJ Duffy
CURRENT PHARMACEUTICAL DESIGN (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
The loss of TGF-β signaling promotes prostate cancer metastasis
WH Tu et al.
NEOPLASIA (2003)
Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model
T Igawa et al.
PROSTATE (2002)